Apteka Kłodzka Jolanta Rawskasp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-19
Registered address
Tadeusza Kościuszki 13, 57-300 Kłodzko, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 43 days early.

  • 202526/06/2026
  • 202411/07/2025
  • 202331/05/2024
  • 202229/06/2023
  • 202105/07/2022
  • 202007/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.62mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 57.90kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 3.54mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 578.51kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Kłodzka Jolanta Rawska has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 2.36k. All its contracts were worth USD 3.56k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesdolnośląskie2USD 2.36k

Ownership

Owner
Agata Agnieszka Luniakage 48
Jolanta Rawskaage 76
Marian Rawskiage 77

Manner of representation

All partners are authorised to represent the company: Jolanta Rawska, Marian Rawski and Agata Luniak, provided that each partner has the right to submit declarations of will on behalf of the company independently.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1997-09-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $20,873.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,249
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,897
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,942

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cefarm RzeszówS.A.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.

FAQ

Last updated: 2026-07-09